Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000819050-21-000029
Filing Date
2021-03-09
Accepted
2021-03-09 16:13:58
Documents
69
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bbi-20201231.htm   iXBRL 10-K 1630981
2 EX-4.8 a2020123110kex48.htm EX-4.8 19474
3 EX-10.7 a2020123110kex107.htm EX-10.7 16465
4 EX-10.25 a2020123110kex1025.htm EX-10.25 50513
5 EX-21.1 a2020123110kex211.htm EX-21.1 4556
6 EX-23.1 a2020123110kex231.htm EX-23.1 9849
7 EX-31.1 a2020123110kex311.htm EX-31.1 10123
8 EX-31.2 a2020123110kex312.htm EX-31.2 9824
9 EX-32.1 a2020123110kex321.htm EX-32.1 8922
  Complete submission text file 0000819050-21-000029.txt   6706873

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20201231.xsd EX-101.SCH 45223
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20201231_cal.xml EX-101.CAL 70512
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20201231_def.xml EX-101.DEF 258882
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20201231_lab.xml EX-101.LAB 618665
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20201231_pre.xml EX-101.PRE 390650
15 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20201231_htm.xml XML 832747
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21088 | Film No.: 21725921
SIC: 2836 Biological Products, (No Diagnostic Substances)